In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains

ConclusionUsing double carbapenem antibiotics with colistin could be a potential alternative to treat colistin and carbapenem-resistantK. pneumoniae. The present study is the first Turkish report of OXA –181-type carbapenemase causing colistin resistance.
Source: Antimicrobial Resistance and Infection Control - Category: Infectious Diseases Source Type: research